Addex Therapeutics

Addex Therapeutics

Model MGLU4 PAM - Treatment of Parkinson’s Disease (PD)

From

0

We are developing mGlu4 PAM as a novel orally available treatment for Parkinson's disease. We are currently optimizing multiple chemical series of highly selective mGlu4 PAMs with compounds in early lead optimization.

Customer reviews

No reviews were found for Model MGLU4 PAM - Treatment of Parkinson’s Disease (PD). Be the first to review!